Eli Lilly and Company (NYSE:LLY) Trading 3.9% Higher on Analyst Upgrade

Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?

While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects.

Eli Lilly and Company (NYSE:LLY) Trading 3.9% Higher on Analyst Upgrade

Eli Lilly and Company (NYSE:LLY – Get Free Report) shares were up 3.9% on Monday after Wall Street Zen upgraded the stock from a buy rating to a strong-buy rating. The company traded as high as $901.34 and last traded at $896.1510. Approximately 5,391,711 shares were traded during mid-day trading, an increase of 34% from […]